MYELOPROLIFERATIVE NEOPLASMS
Clinical trials for MYELOPROLIFERATIVE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASMS trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to control rare blood cancers
Disease control Recruiting nowThis early-stage study tests a new drug, INCA033989, given alone or with another drug (ruxolitinib) in people with certain blood cancers (myeloproliferative neoplasms). The main goals are to check safety and find the best dose. About 290 adults with these cancers will take part.
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New drug trial hopes to tame rare blood cancers
Disease control Recruiting nowThis early-stage study tests a new drug, INCA035784, for safety in 120 adults with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Participants must have a specific gene mutation (CALR) and have tried other treatments. The main goal is to check for side effect…
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC